For example, Parvathaneni et al. used transferrin ligand-modified nanoparticles (Tf-AMQ NPs) to treat non-small cell lung cancer, which effectively penetrated the tumor core and inhibited tumor growth. Here, TF is linked to non-small cell lung carcinoma.